CanadaBuys #W6369-27-A041

Procurement of 10 mg Naloxone Auto-Injectors and Training Devices for Canadian Armed Forces

The Department of National Defence (DND) of Canada is seeking to procure specialized medical devices for the Canadian Armed Forces: - Government Buyer: - Department of National Defence (DND) - Strategic Medical Countermeasures Program on behalf of Canadian Forces Health Services Group - Senior Procurement Officer: D Svcs C 3-3-3-7 - Products Requested: - 3,600 units of 10 mg Naloxone Hydrochloride Auto-Injectors - Intended for emergency treatment and prophylaxis of respiratory depression caused by high-potency opioids - Must have regulatory approval from Health Canada, FDA, or EMA - Minimum 36-month shelf life required - Specific dosage strength: 10 mg - 200 reusable training devices - Designed to replicate operational use for safe handling and training - OEMs and Vendors: - Kaléo, Inc. is identified as the sole supplier and original equipment manufacturer (OEM) capable of meeting all technical and regulatory requirements - Unique/Notable Requirements: - Regulatory approval from Health Canada, FDA, or EMA - Exclusive rights and intellectual property held by Kaléo, Inc. - Procurement conducted as an Advance Contract Award Notice (ACAN) due to absence of competition for technical reasons - Products must meet operational criteria for emergency opioid overdose response - Contract Details: - Initial contract duration of 28 months from award - Two one-year option periods, potentially extending performance to March 31, 2031

Description

The Department of National Defence (DND), through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, requires the supply of 3,600 units of 10 mg Naloxone Auto-injectors and 200 reusable training devices. These devices are intended for emergency treatment and/or prophylaxis of respiratory depression where high-potency opioid use is confirmed or suspected. The contract duration is 28 months starting from November 20, 2026, with potential extensions to March 31, 2031. The procurement method is an Advance Contract Award Notice (ACAN) with the contract expected to be awarded to Kaléo, Inc., the sole known supplier meeting the requirements.

View original listing